Specifications
| Item Number | 321902 |
|---|
| Administration Form | Oral |
|---|
| Common Brand Name(s) | Atopica |
|---|
| For Use With | Dogs |
|---|
| Generic Name | Cyclosporine |
|---|
| Lifestage | Adult |
|---|
| Product Form | Liquid |
|---|
| Health Condition | Allergies |
|---|
| Drug Type | Immunosuppressant |
|---|
Uses
CYCLAVANCE is indicated for the control of atopic dermatitis in dogs weighing at least 4 lbs (1.8 kg) body weight.
Possible Side Effects
Side effects include vomiting， diarrhea， pruritus， depression， and lethargy
Drug & Food Interactions
CYCLAVANCE should be used with caution with drugs that affect the P-450 enzyme system. Simultaneousadministration of CYCLAVANCE with drugs that suppress the P-450 enzyme system， such as azoles (e.g. ketoconazole)， may lead to increased plasma levels of cyclosporine. Killed vaccines are recommended for dogs receiving CYCLAVANCE because the impact of cyclosporine on theimmune response to modified live vaccines is unknown.
Precautions
Wear gloves during and wash hands after administration. Gastrointestinal problems and gingival hyperplasia may occur at the initial recommended dose of cyclavance oral solution for dogs. Cyclavance oral solution for dogs should be used with caution: 1. in cases with diabetes mellitus as it may cause elevated levels of serum glucose.2 in dogs with renal insufficiency since the effect of cyclosporine use on dogs with compromised renal function has not been studied Cyclvance is contraindicated for use in dogs with a history of neoplasia. Do not use in dogs with a hypersensitivity to cyclosporine. Cyclavance is a systemic immunosuppressant that may increase the susceptibility to infection and the development of neoplasia.
Comment